CN109876158A - Application of the vitamin C as elimination upper digestive tract iodine staining to mucosal irritation drug - Google Patents

Application of the vitamin C as elimination upper digestive tract iodine staining to mucosal irritation drug Download PDF

Info

Publication number
CN109876158A
CN109876158A CN201910186576.4A CN201910186576A CN109876158A CN 109876158 A CN109876158 A CN 109876158A CN 201910186576 A CN201910186576 A CN 201910186576A CN 109876158 A CN109876158 A CN 109876158A
Authority
CN
China
Prior art keywords
vitamin
iodine
solution
digestive tract
upper digestive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910186576.4A
Other languages
Chinese (zh)
Inventor
张国新
金多晨
许迎红
叶峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201910186576.4A priority Critical patent/CN109876158A/en
Publication of CN109876158A publication Critical patent/CN109876158A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Application the present invention relates to vitamin C as elimination upper digestive tract iodine staining to mucosal irritation drug.The present invention sprays Lushi's iodine solution in upper digestive tract Endoscopy, takes vitamin c solution.The present invention overcomes the defects that past Endoscopy sprinkling Lushi's iodine solution has strong impulse and toxicity to oesophagus and gastric mucosa.Vitamin c solution of the present invention can be relieved upper digestive tract Endoscopy iodine staining subject's mucosal irritation symptom, and patient is made more to be easily accepted by dye endoscopy, mitigate patient suffering.

Description

Application of the vitamin C as elimination upper digestive tract iodine staining to mucosal irritation drug
Technical field
The present invention relates to pharmaceutical technology field, in particular to vitamin C pierces mucous membrane as elimination upper digestive tract iodine staining Swash the application of drug.
Background technique
Before making the present invention, Endoscopy is the diagnosis common auxiliary examination method of tumor in upper digestive tract, is clinically commonly used Endolumenal local sprays 2% Lushi's iodine solution and dyes to suspicious lesions mucous membrane.Contain free iodine and iodine in Lushi's iodine solution Change potassium, be both strong oxidizer, there is strong impulse and toxicity to oesophagus and gastric mucosa, therefore dye in Endoscopy In the process with inspection after, patient will appear burn feeling and oesophagismus after different degrees of breastbone, and serious person can lead to The lesions such as mucosal erosion, ulcer, bleeding or even cardiopulmonary arrest, which greatly limits the universal of Endoscopy, Increase the pain of dye endoscopy.
Currently, clinically using vitamin C as a kind of nutritional supplement, and can be used for scurvy, chronic iron poisoning, special hair The treatment of property methemoglobinemia etc..
Summary of the invention
The object of the invention is that overcoming drawbacks described above, vitamin C is developed as elimination upper digestive tract iodine staining to viscous The application of film stimulating drug.
The technical scheme is that
Application of the vitamin C as elimination upper digestive tract iodine staining to mucosal irritation drug, it is characterised in that: in upper digestion Road Endoscopy sprays Lushi's iodine solution, takes vitamin c solution.
The Vitamin C content is 1-4% vitamin C.
The Vitamin C content is 2% vitamin C.
Advantages of the present invention and effect are:
1. sprinkling vitamin c solution has endolumenal local iodine staining significant compared with not spraying vitamin c solution Fading effect.
2. being sprayed in vitamin c solution and in iodine staining patient gastroscopy procedures compared with not spraying vitamin c solution And check terminate half an hour it is less there is iodine irritation, there are slight iodine irritation patients in minority, can alleviate quickly.
3. spraying in vitamin c solution compared with not spraying vitamin c solution and adverse events occurring in iodine staining patient Possibility is lower, and severity is lighter.
Vitamin c solution can be relieved upper digestive tract Endoscopy iodine staining subject's mucosal irritation symptom, be easier to patient Receive dye endoscopy, mitigates patient suffering.
Detailed description of the invention
Fig. 1 --- in vitamin C of the present invention and Lushi's iodine staining effect diagram, left figure are endolumenal local spray Scheme after spilling 2% Lushi's iodine solution of 10ml, right figure be 2% vitamin c solution of 20ml in and iodine staining element effect picture.
Fig. 2 --- zoopery figure of the present invention;Wherein, A substantially schemes for mucous membrane of esophagus before Lu Ge Shi iodine staining, from left to right Esophageal tissue is belonging respectively to normal saline flushing group, in sodium thiosulfate and in group, vitamin C and group;B is sprinkling Lu Ge Shi iodine Dyeing liquor figure, it is seen that 3 pieces of esophageal tissues are dyed to brown;C is that oesophagus iodine dye figure is removed using different disposal method, wherein left Normal saline flushing passes through in side esophageal tissue, and discovery still remains obvious brown, and intermediate esophageal tissue is using in sodium thiosulfate It is contaminated with iodine, sodium thiosulfate belongs to strong reducing property chemical reagent, though iodine dye can be neutralized, is easy to not as good as vitamin C in clinic It obtains and safety, right side esophageal tissue is to contaminate using in 2% vitamin C with iodine, it is seen that it is colourless that brown iodine dye takes off completely;D is Esophageal tissue after iodine is contaminated and by distinct methods removing iodine dye is through 4% paraformaldehyde soaked overnight, and paraffin embedding HE contaminates Color, as a result, it has been found that vitamin C not will cause Esophageal mucosa injury and inflammation.
Specific embodiment
Technical thought of the invention:
Vitamin C is microelement important in human body, and a variety of important biomolecule chemical reactions in participant's body are able to maintain The integrality of human body cell and vascular stroma.Vitamin C is a kind of organic monoacid, is a kind of natural reducing agent, is had excellent Antioxidation.The present invention will utilize this characteristic of vitamin C.Make Lushi's iodine solution main component iodine using vitamin c solution Redox reaction has occurred in simple substance, so that eliminating Lushi's iodine solution has strong impulse and poison to oesophagus and gastric mucosa Property.
The present invention is specifically described below.
After upper digestive tract Endoscopy sprays Lushi's iodine solution and completes to the observation at suspicious lesions position, continue to spray Vitamin c solution.Vitamin C content is 1-4% vitamin C, and vitamin C optimum content is 2% vitamin C, can be made into solution Sprinkling.
Its mechanism is:
Redox reaction has occurred in vitamin c solution and Lushi's iodine solution main component elemental iodine, and reaction equation is such as Under:
C6H8O6(Vit C, ascorbic acid)+I2=C6H6O6(hydroascorbic acid)+2HI
Currently, clinically adult common vitamin C oral dose is 200mg tid, i.e. daily intake 600mg, maximum Dosage is injected intravenously up to 3g/d.Ascorbic oral median lethal dose (LD50) be 11.9g/kg, take orally the scope of application it is wide and Safety.The present invention is sprayed at using 2% vitamin c solution of 20ml at Lushi's iodine iodine dye, is equal to once oral 400mg dimension Raw element C, belongs to clinical common oral dose, and safety is good.
As it can be seen that the vitamin c solution of 2% concentration is as a kind of natural reducing agent, and does not damage gastrointestinal mucosal, have latent Be applied to Endoscopy in and Lushi's iodine staining prospect.
Fig. 1 be 2% vitamin c solution of 20ml in and 2% Lushi's iodine staining effect of 10ml.Wherein, left figure is under scope After 2% Lushi's iodine solution of localized pulverization 10ml, right figure be 2% vitamin c solution of 20ml in and iodine staining element effect.
It is as shown in Figure 2:
Overall length oesophagus is taken rapidly after 36 monthly age Yorkshires euthanasia, is divided into 3 parts.4 DEG C of pre-cooling PBS buffer solution drifts It washes, removes esophageal contents and blood stains.2%, which is uniformly sprayed, in mucous membrane of esophagus face now matches Lushi's iodine dye liquor, after 2 minutes, respectively at Mucous membrane of esophagus face sprinkling same amount of normal saline, 5% hypo solution, 2% vitamin c solution simultaneously observe each group colour fading effect Fruit.Oesophagus after processing is immersed in 4% paraformaldehyde overnight, embedding paraffin section is taken out and does HE dyeing, is further looked at 2% vitamin c solution has not damaged and whether acute inflammatory reaction occurs to mucous membrane of esophagus integrality.NS: physiological saline;STS: Hypo solution;VCS: vitamin c solution.A figure: each group mucous membrane of esophagus is substantially seen before iodine contaminates;B figure: each group is eaten after iodine dye Pipe mucous membrane is substantially seen;C figure: each group mucous membrane of esophagus is respectively adopted physiological saline, hypo solution, vitamin c solution and rinses Discoloration afterwards;D figure: each group mucous membrane of esophagus HE staining conditions (× 200 times).
It proves in vitamin C and Lu Ge Shi iodine staining has safety and validity.
Table 1 is various concentration vitamin c solution and different configuration proportion Lushi iodine solution mixing rear decolorings required times
Note: this experiment is respectively by free iodine: potassium iodide is made into Lu of 10ml different proportion in 1: 1,1: 1.5,1: 2 ratio Ge Shi iodine solution, wherein be current clinically used Lushi iodine solution configuration proportion at 1: 2.We prepare vitamin C in physiology In salt water, it is mixed into the vitamin c solution of 0%, 1%, 2%, 4% different proportion of 20ml, by Lu Ge Shi of 10ml different proportion Iodine solution is mixed with the vitamin c solution of 20ml different proportion, as a result, it has been found that cannot make in 0% vitamin c solution 5min time Lu's Ge Shi iodine solution brown is faded, and 1%-4% vitamin c solution can make iodine solution fade, and 2% vitamin c solution is in 5 seconds It is colourless that the brown of iodine solution can be made, which to take off,.It can be seen that 1%-4% vitamin C can neutralize iodine dye, wherein 2% vitamin c solution is most Good concentration.

Claims (3)

1. application of the vitamin C as elimination upper digestive tract iodine staining to mucosal irritation drug, it is characterised in that: in upper digestive tract Endoscopy sprays Lushi's iodine solution, takes vitamin c solution.
2. being answered as upper digestive tract iodine staining is eliminated mucosal irritation drug according to vitamin C as stated in claim 1 With, it is characterised in that: the Vitamin C content is 1-4% vitamin C.
3. being answered as upper digestive tract iodine staining is eliminated mucosal irritation drug according to vitamin C described in claim requirement 2 With, it is characterised in that: the Vitamin C content is 2% vitamin C.
CN201910186576.4A 2019-03-12 2019-03-12 Application of the vitamin C as elimination upper digestive tract iodine staining to mucosal irritation drug Pending CN109876158A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910186576.4A CN109876158A (en) 2019-03-12 2019-03-12 Application of the vitamin C as elimination upper digestive tract iodine staining to mucosal irritation drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910186576.4A CN109876158A (en) 2019-03-12 2019-03-12 Application of the vitamin C as elimination upper digestive tract iodine staining to mucosal irritation drug

Publications (1)

Publication Number Publication Date
CN109876158A true CN109876158A (en) 2019-06-14

Family

ID=66931994

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910186576.4A Pending CN109876158A (en) 2019-03-12 2019-03-12 Application of the vitamin C as elimination upper digestive tract iodine staining to mucosal irritation drug

Country Status (1)

Country Link
CN (1) CN109876158A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110201190A (en) * 2019-06-27 2019-09-06 施瑞华 A kind of coloring agent and preparation method thereof for cancer of the esophagus early diagnosis
CN111346238A (en) * 2020-01-21 2020-06-30 金多晨 Kit for esophageal mucosa staining

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103623434A (en) * 2013-12-06 2014-03-12 江苏省人民医院 Compound iodine staining diagnostic kit set for esophageal mucosa
CN105396148A (en) * 2015-11-26 2016-03-16 江苏诚品生物科技有限公司 Esophageal-mucosa staining combination set

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103623434A (en) * 2013-12-06 2014-03-12 江苏省人民医院 Compound iodine staining diagnostic kit set for esophageal mucosa
CN105396148A (en) * 2015-11-26 2016-03-16 江苏诚品生物科技有限公司 Esophageal-mucosa staining combination set

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
SUDHA J. DEVAKI等: "Vitamin C: Sources, Functions, Sensing and Analysis", 《INTECHOPEN》 *
林明环等: "维生素C去除医用碘类污染", 《健康必读》 *
王坤等: "中西医结合治疗鼻咽癌放疗后咽炎疗效观察 ", 《中国中西医结合耳鼻咽喉科杂志》 *
荣雪萍: "维生素C溶液用于眼部冲洗脱碘", 《中国冶金工业医学杂志》 *
莫玉芳等: "复方碘滴鼻液的制备及临床应用 ", 《中国医院药学杂志》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110201190A (en) * 2019-06-27 2019-09-06 施瑞华 A kind of coloring agent and preparation method thereof for cancer of the esophagus early diagnosis
CN110201190B (en) * 2019-06-27 2021-12-14 施瑞华 Coloring agent for early diagnosis of esophageal cancer and preparation method thereof
CN111346238A (en) * 2020-01-21 2020-06-30 金多晨 Kit for esophageal mucosa staining

Similar Documents

Publication Publication Date Title
JP2643669B2 (en) Algin-containing foods
JP2774106B2 (en) Laxative aqueous solution
CN105963701A (en) Method, composition and package for bowel cleansing
CN109876158A (en) Application of the vitamin C as elimination upper digestive tract iodine staining to mucosal irritation drug
JP2007521238A (en) Sponge-based therapeutic compositions for the treatment and prevention of skin diseases
EP0326826B1 (en) Medicine with a destructive effect on malignant tumours, process for its manufacture and preparation for use in the therapy of cancer patients
DE3319575A1 (en) THERAPEUTICALLY EFFECTIVE COMPOSITIONS, FOOD AND BEVERAGES
CN110201190B (en) Coloring agent for early diagnosis of esophageal cancer and preparation method thereof
CN108210477A (en) Delay flexible glue cyst fluid, soft capsule and the forefront capsule and its preparation method of rubber aging
Coleman et al. The toxicology of essential and nonessential metals
Jin et al. The safety and efficacy of 2% vitamin C solution spray for relief of mucosal irritation caused by Lugol chromoendoscopy: a multicenter, randomized, double-blind, parallel trial
WO2022055286A1 (en) Bowel-cleansing composition
CN106361741B (en) A kind of chlorophyll composition for being used to treat constipation
EP3247323B1 (en) Chlorophyll composition
Linton et al. Muscle necrosis and acute renal failure in carbon monoxide poisoning.
Kang et al. Chilli ingestion does not lead to macroscopic gastroduodenal mucosal damage in healthy subjects
WO2004047832A1 (en) Agent having a destructive effect on malignant tumors and method for the production thereof
RU2297234C2 (en) Fukolamine preparation for preventing and treating gastroenteric and endocrine system diseases
JPH08205807A (en) Production of aged, concentrated garlic solution free from foul breath
RU2441659C2 (en) Remedy for treatment of kidney stone disease and urogenital system cysts
FLAUM et al. Hemochromatosis: Report of a Case with Necropsy and Analysis of the Liver
Farrow Hair dye and henna tattoo exposure
WO2023026231A1 (en) Composition for the prevention and/or treatment of gastric and esophageal diseases
AU2020202375A1 (en) Composition for Prophylaxis of Colon Cancer
RU2071778C1 (en) Method of preparing agent showing antitumor activity

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20190614

RJ01 Rejection of invention patent application after publication